9-(2-C-cyano-2-deoxy-β-D-arabino-pentofuranosyl)guanine, a potential antitumor agent against B-lymphoma infected with Kaposi's sarcoma-associated herpesvirus

Journal of Medicinal Chemistry

Volumn 50, Issue 9, 2007, Pages 2007-2010

  Ohtawa, Masaki ^a   Ichikawa, Satoshi ^a   Teishikata, Yasuhiro ^a   Fujimuro, Masahiro ^a   Yokosawa, Hideyoshi ^a   Matsuda, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

9 (2 C CYANO 2 DEOXY 1 BETA DEXTRO ARABINOPENTOFURANOSYL)GUANINE; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CYTOTOXICITY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; REACTION ANALYSIS; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS; ARABINONUCLEOSIDES; CELL LINE, TUMOR; DNA; EPSTEIN-BARR VIRUS INFECTIONS; GUANOSINE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, B-CELL; RNA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34247567791     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070032y     Document Type: Article

References (28)

1. Jenner, R. G.; Boshoff, C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim. Biophys. Acta 2002, 1602, 1-22.
2. Ablashi, D. V.; Chatlynne, L. G.; Whitman, J. E.; Cesarman, E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin. Microbiol. Rev. 2002, 15, 439-464.
3. Chang, Y.; Cesarman, E.; Pessin, M. S.; Lee, F.; Culpepper, J.; Knowles. D. M.; Moore, P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266, 1865-1869.
4. Glesby, M. J.; Hoover, D. R.; Weng, S.; Graham, N. M.; Phair, J. P.; Detels, R.; Ho, M.; Saah, A. J. Use of antiherpes drugs and the risk of Kaposi's sarcoma: Data from a multicenter AIDS cohort study. J. Infect. Dis. 1996, 93, 14862-14867.
5. Mocroft, A.; Youle, M.; Gazzard, B.; Morcinek, J.; Halai, R.; Phillips, A. N. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. AIDS 1996, 10, 1101-1105.
6. Mazzi, R.; Parisi, S. G.; Sarmati, L.; Uccella, I.; Nicastri, E.; Carolo, G.; Gatti, F.; Concia, E.; Andreoni, M. Efficacy of cidofovir on human ferpesvirus 8 viremia and Kaposi's sarcoma progression in two patients with AIDS. AIDS 2001, 15, 2061-2063.
7. Fife, K.; Gill, J.; Bourboulia, D.; Gazzard, B.; Nelson, M.; Bower, M. Cidofovir for the treatment of Kaposi's sarcoma in an HIV-negative homosexual man. Br. J. Dermatol. 1999, 141, 1148-1150.
8. Little, R. F.; Merced-Galindez, F.; Staskus, K.; Whitby, D.; Aoki, Y.; Humphrey, R.; Pluda, J. M.; Marshall, V.; Walters, M.; Welles, L.; Rodriguez-Chavez, I. R.; Pittaluga, S.; Tosato, G.; Yarchoan, R. A pilot study of cidofovir in patients with Kaposi sarcoma. J. Infect. Dis. 2003, 187, 149-153.
9. Casper, R. Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection. Herpes 2006, 13, 42-47.
10. Matsuda, A.; Nakajima, Y.; Azuma, A.; Tanaka, M.; Sasaki, T. Nucleosides and nucleotides. 100. 2′-C-Cyano-2′-deoxy-1-β-D- arabinofuranosylcytosine (CNDAC): Design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside. J. Med. Chem. 1991, 34, 2917-2919.
11. Azuma, A.; Nakajima, Y.; Nishizono, N.; Minakawa, N.; Suzuki, M.; Hanaoka, K.; Kobayashi, T.; Tanaka, M.; Sasaki, T.; Matsuda, A. Nucleosides and nucleotides. 122. 2′-C-Cyano-2′-deoxy-1-β-D- arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum. J. Med. Chem. 1993, 36, 4183-4189.
12. Tanaka, M.; Matsuda, A.; Terao, T.; Sasaki, T. Antitumor activity of a novel nucleoside, 2′-C-cyano-2′-deoxy-1-β-D- arabinofuranosylcytosine (CNDAC) against murine and human tumors. Cancer Lett. 1992, 64, 67-74.
13. Azuma, A.; Hanaoka, K.; Kurihara, A.; Kobayashi, T.; Miyauchi, S.; Kamo, N.; Tanaka, M.; Sasaki, T.; Matsuda, A. Nucleosides and nucleotides. 141. Chemical stability of a new antitumor nucleoside, 2′-C-cyano- 2′-deoxy-1-β-D-arabino-pentofuranosylcytosine alkaline medium: Formation of 2′-C-cyano-2-deoxy-1-β-D-ribo- pentofuranosylcytsine and its antitumor activity. J. Med. Chem. 1995, 38, 3391-3397.
14. Matsuda, A.; Azuma, A. 2′-C-Cyano-2′-deoxy-1-β-D- arabinofuranosylcytosine (CNDAC): A mechanism-based DNA-strand-breaking antitumor nucleoside. Nucleosides Nucleotides 1995, 14, 461-471.
15. Azuma, A.; Huang, P.; Matsuda, A.; Plunkett, W. 2′-C-Cyano- 2′-deoxy-1-β-D-arabino-pentofuranosylcytosine (CNDAC): A novel acting anticancer nucleoside analog that causes DNA strand-breaks and G2 arrest. Mol. Pharmacol. 2001, 59, 725-731.
16. Azuma, A.; Huang, P.; Matsuda, A.; Plunkett, W. Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2′-C-cyano- 2′-deoxy-1-β-D-arabino-pentofuranosylsytosine (CNDAC). Biochem. Pharmacol. 2001, 61, 1497-1507.
17. Matsuda, A.; Sasaki, T. Antitumor activity of sugar-modified cytosine nucleosides. Cancer Sci. 2004, 95, 105-111.
18. Wunk, S. F.; Lewandowska, E.; Companioni, D. R.; Garcia, P. I., Jr.; Secrist J. A., III. Synthesis and cytotoxicity of 9-(2-deoxy-2-alkyldithio- β-D-arabinofuranosyl)purine nucleosides which are stable precursors to potential mechanistic probes of ribonucleoside reductase. Org. Biomol. Chem. 2004, 2, 120-126.
19. Beigelman, L.; Haeberli, P.; Sweedler, D.; Karpeisky, A. Improved synthetic approaches toward 2′-O-methyl-adenosine and guanosine and their N-acyl derivatives. Tetrahedron 2000, 56, 1047-1056.
20. Robins, M. J.; Wilson, J. S. Nucleic acid related compounds. 41. Restricted furanose conformations of 3′,5′-O-(1,1,3,3- tetraisopropyl-disilox-1,3-diyl)nucleosides provide a convenient evaluation of anomeric configuration. Can. J. Chem. 1983, 61, 1911-1920.
21. Nair, V.; Sells, T. B. Enzymic synthesis of 2′,3′- dideoxyguanosine. Synlett 1991, 753-754.
22. Almond, M. R.; Collins, J. L.; Reitter, B. E.; Rideout, J. L.; Freeman, G. A.; St Clair, M. H. Synthesis of 2-amino-9-(3′-azido-2′,3′- dideoxy-beta-D-erythro-pentofuranosyl)-6-methoxy-9H-purine (AzddMAP) and AzddGuo. Tetrahedron Lett. 1991, 32, 5745-5748.
23. Garegg, P. J.; Hoffman, J.; Lindberg, B.; Samuelsson, B. Synthesis of 6-deoxy-D-altro-heptose. Carbohydr. Res. 1978, 67, 263-266.
24. Fujimuro, M.; Inoue, H.; Teishikata, Y.; Yokosawa, H. Apoptotic effect of ganciclovir on lymphoblastoid cells stably harboring KSHV and EBV. Nucleosides Nucleotides Nucleic Acids 2006, 25, 635-645.
25. Cannon, J. S.; Hamzeh, F.; Moore, S.; Nicholas, J.; Ambinder, R. F. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. J. Virol. 1999, 73, 4786-4793.
26. Gustafson, E. A.; Schinazi, R. F.; Fingeroth, J. D. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. J. Virol. 2000, 74, 684-692.
27. Lock, M. J.; Thorley, N.; Teo, J.; Emery, V. C. Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase. J. Antimicrob. Chemother. 2002, 49, 359-366.
28. 2+-mobilizing agent 3″-deoxycyclic ADP-carbocyclic-ribose provides partial agonists. Bioorg. Med. Chem. 2007, 15, 3032-3040.